Volker Rudolph

Interventional cardiologist / Cardiologist
Heart and Diabetes Center NRW - Bad Oeynhausen, Germany

Latest contributions

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

TAV-in-TAV for transcatheter heart valve failure

26 Nov 2024 – From PCR London Valves 2024

Struggling with transcatheter heart valve failure? Don’t miss this video!

Learn the essential steps for planning a re-do TAVI procedure, from analysing CT scans to using the re-do TAVI app for a TAV-in-TAV approach, and watch a real-life case of a 91-year-old patient undergoing a redo procedure...

TAV-in-TAV for transcatheter heart valve failure

A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system

25 Nov 2024 – From PCR London Valves 2024

Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...

A window into the future - Expanding horizons for patients with long life expectancy with the Evolut

TAVI for aortic regurgitation

25 Nov 2024 – From PCR London Valves 2024

Curious about advancing your knowledge in TAVI for aortic regurgitation? Don’t miss this video!

You'll dive into the diagnostic and treatment strategies to optimize outcomes in patients with aortic regurgitation, explore groundbreaking technologies like the Jenavalve Trilogy THV system and gain insights from the latest clinical evidence and...

TAVI for aortic regurgitation

TAVI in women - Recent trials and current understanding

25 Nov 2024 – From PCR London Valves 2024

Looking to learn more about gender-based differences in the presentation and management of aortic stenosis? Dont' miss this video on the specifics of TAVI in women!

You'll discover how aortic stenosis presents uniquely in female patients, review the latest data on TAVI outcomes in women, and gain...

TAVI in women - Recent trials and current understanding

How to achieve optimal results in tricuspid valve interventions?

15 May 2024 – From EuroPCR 2024

How to achieve optimal results in tricuspid valve interventions?

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

Tricuspid TEER - Part 2

20 Nov 2023 – From PCR London Valves 2023

Complex transcatheter mitral and tricuspid interventions - Recorded cases

20 Nov 2023 – From PCR London Valves 2023

This session features two compelling cases of percutaneous annuloplasty for advanced heart failure and massive tricuspid regurgitation: 

  1. Left ventricular restoration in heart failure with reduced ejection fraction
    A 56-year-old male, with type 2 diabetes, hypertension and chronic kidney disease, presented a symptomatic severe LV dysfunction (26%) and severely...
Complex transcatheter mitral and tricuspid interventions

The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning

20 Nov 2023 – From PCR London Valves 2023

This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.

Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?

19 Nov 2023 – From PCR London Valves 2023

Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!

How does the role of the right heart and pulmonary vasculature influence patient selection?

Tailoring tricuspid regurgitation patient treatment with the PASCAL Precision system

17 May 2023 – From EuroPCR 2023

Watch this session to discuss exciting cases of tricuspid regurgitation, learn about the proposed new integrated classification for tricuspid regurgitation and enjoy a live presentation of the PASCAL Precision Repair System using a beating heart simulator, among others!

Transcatheter mitral valve therapies beyond TEER

17 May 2023 – From EuroPCR 2023

Take a ride into the realm of transcatheter mitral valve therapy, going beyond the limits of TEER. Discover the captivating complexities and innovative strategies in this dynamic field, starting with a compelling initial case: transcatheter mitral valve replacement (TMVR) utilizing a semi-rigid flexible three-dimensional annuloplasty ring.

Transcatheter mitral valve therapies

Reinventing the treatment of patients with tricuspid valve disease

28 Nov 2022 – From PCR London Valves 2022

This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.

Secondary mitral regurgitation: challenges in management

28 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.

Secondary mitral regurgitation: challenges in management

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.

Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up

A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation

19 May 2022 – From EuroPCR 2022

In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.

PCR Tricuspid Focus Group update: present and future of tricuspid regurgitation treatment

17 May 2022 – From EuroPCR 2022

Follow the discussions based on the case of an 85-year-old male patient with HTN, mild secondary PAH, DCM, LVEF 45 %, and surgical bioAVR and MVR, presenting with progressive SOB and signs of right HF, severe secondary TR 4/5, and permanent AF, and note the indications of...

PCR Tricuspid Focus Group update: present and future of tricuspid regurgitation treatment

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation

22 Nov 2021 – From PCR London Valves 2021

In this session broadcast at PCR London Valves 2021, discuss and explore transcatheter therapies for the treatment of tricuspid regurgitation and their clinical impact, analyze the recorded live case of an 81-year-old female patient from Leipzig, and discover the potential of transcatheter replacement technologies in the...

Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation

Advancing mitral and tricuspid repair with the PASCAL repair system platform

23 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to uncover clinical impact of PASCAL repair system platform for MR and TR treatment, to see a recorded case using PASCAL Ace in MR and to discover the potential of transcatheter repair for the treatment of TR.

Advancing mitral and tricuspid repair with the PASCAL repair system platform